When used as part of a comprehensive health strategy, microdosing GLP 1 medications can become a tool for metabolic resilience rather than a temporary solution

Water, Centella Asiatica Extract (12.3%), Glycerin, Cetyl Ethylhexanoate, Cetearyl Alcohol, Glyceryl Stearate, Glutathione (1,000ppm), Niacinamide (1,000ppm), Madecassic Acid, Asiaticoside, Asiatic Acid, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Squalane, Sodium Hyaluronate, Dipropylene Glycol, Butylene Glycol, Hydrogenated Lecithin, Cholesterol, Xanthan Gum, Potassium Hydroxide, Disodium EDTA, Caprylic/Capric Triglyceride, Cyclopentasiloxane, Cyclohexasiloxane, Saccharide Hydrolysate, Sorbitan Stearate, Dimethicone, PEG-100 Stearate, Stearic Acid, 1,2-Hexanediol, Chlorphenesin, Carbomer, Caprylyl Glycol *For the most recent ingredient list, please consult the product packaging or contact us for a product photo.

Peptides and peptide aggregates can trigger immune responses, but the likelihood for a specific preparation depends on sequence, purity, formulation, route, storage, patient factors, and repeated exposure
Polymorphic light eruption and actinic keratosis: MT1 has been studied in Phase 3 trials for polymorphic light eruption and Phase 2 trials for actinic keratosis and squamous cell carcinoma, reflecting interest in its broader photoprotective potential